Natixis Advisors, L.P. Prestige Consumer Healthcare Inc. Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 287,996 shares of PBH stock, worth $18.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
287,996
Previous 208,186
38.34%
Holding current value
$18.1 Million
Previous $17.9 Million
28.48%
% of portfolio
0.04%
Previous 0.03%
Shares
26 transactions
Others Institutions Holding PBH
# of Institutions
397Shares Held
52.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.28MShares$520 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$354 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.47MShares$155 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.2MShares$138 Million2.24% of portfolio
-
State Street Corp Boston, MA2MShares$126 Million0.01% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $3.13B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...